Non-tech firms hike innovation strategies
A growing number of Indiana corporations are formalizing in-house innovation, an effort aimed at remaining technologically relevant in a fast-changing business landscape.
A growing number of Indiana corporations are formalizing in-house innovation, an effort aimed at remaining technologically relevant in a fast-changing business landscape.
Eli Lilly and Co. announced the “strategic research collaboration” Thursday morning, calling it the largest agreement of its kind between Purdue and a single company.
Britain's Supreme Court has ruled in favor of Eli Lilly and Co. in a patent dispute with generic drugmaker Actavis over Lilly's Alimta cancer treatment.
Drugmakers like Eli Lilly and Co. plunged off a patent cliff earlier this decade, losing billions in sales as lucrative branded drugs lost exclusivity. An expensive lobbying effort aimed at preventing a repeat is paying off.
The grant from the Indianapolis-based philanthropic giant is aimed at bolstering Indiana’s stature as a life sciences research hub.
The trustee charges that Sam Odle and fellow outside directors should have ousted CEO Kevin Modany—a move that likely would have been well-received by the U.S. Department of Education and ITT’s accrediting agency.
The parent company of Circle Centre mall’s sole anchor, Carson’s, is facing steep challenges, with some retail experts wondering whether it will be the next big chain to collapse.
The deal is Eli Lilly and Co.’s latest push into a growing disease area for such disorders as arthritis, lupus and multiple sclerosis.
The Indianapolis-based drugmaker warned that a much-anticipated new drug for rheumatoid arthritis might be delayed another 18 months.
Global pharmaceutical companies including Indianapolis-based Eli Lilly and Co. are heading into smaller cities and rural areas to learn about the health care needs of about 70 percent of India’s population.
A local company that leases Google Glass devices and sells software on top of it expects revenue to jump from an estimated $1.4 million this year to about $11 million next year.
Jason Vasquez has helped DeveloperTown grow from a small design and development shop working primarily with startups to a well-established agency working with Fortune 500 companies.
How could people in the divided city of Aleppo, Syria, live such different lives? I couldn’t imagine it—until I considered ways our city is divided.
Over the past 20 years, while the price of a gallon of milk climbed 23 percent and the sticker on a Dodge Caravan minivan rose 21 percent, the list price of the insulin Humalog shot up 1,157 percent.
Naomi Pescovitz, a North Central High School graduate, will help to launch a 7 p.m. newscast at KMSP-Fox 9, which she said will “give me my weekends back and I’ll be able to turn off that 1:30 a.m. alarm clock.”
Hospitality tents are going up at the iconic golf course at the Indianapolis Motor Speedway in anticipation of an LPGA Tour event, marking the first time women pros have played in central Indiana in nearly two decades.
The Indianapolis drugmaker said it will not be required to conduct another expensive, time-consuming clinical trial for the potential blockbuster.
David Broecker was founding CEO of the four-year-old Indiana Biosciences Research Institute, which aims to bridge the gap between research universities and industry in life sciences.
Danish drugmaker Novo Nordisk says it has reached a settlement over allegations that it hadn’t properly communicated safety information when marketing a medicine to treat type 2 diabetes.
The Paris flights, announced Wednesday, may lessen the urgency local officials feel to attract a direct flight from Indianapolis to London. Delta Air Lines stands to land $5.5 million in incentives if it can keep the flights filled.